BRCA1 and breast cancer: Our study echoes this trend, as evidenced by our findings on DFS and OS rates among groups categorized by PVs in associated genes (i.e., BRCA1, BRCA2, and HR-DDR or inherited breast cancer cases) and those with PVs in non-associated genes (i.e., other breast cancer cases).